The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis

BACKGROUND: The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), demonstrated its effectiveness for lowering serum phosphate levels, with low daily pill burden, in clinical trials of dialysis patients with hyperphosphatemia. This retrospective database analysis evaluated the real-w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Nephrol
Hlavní autoři: Ramos, Rosa, Chazot, Charles, Ferreira, Anibal, Di Benedetto, Attilio, Gurevich, Konstantin, Feuersenger, Astrid, Wolf, Melanie, Arens, Hans-Jürgen, Walpen, Sebastian, Stuard, Stefano
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720479/
https://ncbi.nlm.nih.gov/pubmed/33287733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-02188-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky